Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Agents for disorders of GABAergic transmission from Synthelabo

March 22, 1999

James Black Foundation describes new H3 ligands

March 22, 1999

Kynurenine pathway enzyme inhibitors from P&U for neuropathological disorders

March 19, 1999

Cerebral metabolic consequences of NOS deficiency in null mice

March 19, 1999

Phase III results support use of memantine in dementia

March 19, 1999

Caspase inhibition by Ac-YVAD-cmk enhances nigral transplant survival

March 19, 1999

Phase III data indicate strong analgesic potency of Roberts' Dirame

March 18, 1999

First approval received for new insomnia Rx

March 18, 1999

NAS supports clinical testing of marijuana, development of new delivery mechanisms

March 18, 1999

Peripheral and Central Nervous System Drugs Advisory Committee meets in April

March 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...